Disclosure of interest: No disclosures E-Posters - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.02 - LIFE AFTER STROKE P2275 - ESOC25-1701 PREVALENCE OF RYANODINE ANTIBODIES IN STROKE PATIENTS WITH POST-STROKE FATIGUE (PSF): AN OBSERVATIONAL ANALYSIS Dr Karthika Pt, Vivek Nambiar 1 , Dr Sudheeran Kannoth 1 , Divyasree Chandran 1 Amrita Institute of Medical Sciences and Research Centre, Kochi, India Background and Aims: Post-stroke fatigue (PSF) is a debilitating sequela of stroke involving central and peripheral mechanisms

Considering again that the myogenic stem cell activator HGF is found in an ECM-bound state 19,20,21,22,26 and undergoes nitration of tyrosine residues (Y198 and Y250) with aging 32,32,62 and muscle disuse (Kuwakdo et al., 2025), the present in vivo experiments provide a robust platform showing the potential for LASSS that could efficiently reduce or delay the nitration-dysfunction of ECM-bound HGF under peroxynitrite-generating conditions
Bioinformatics analysis identifies potential ferroptosis key gene in type 2 diabetic islet dysfunction
This glucose-dependent insulinotropic effect is particularly favorable for diabetes treatment because it avoids the risks of hypoglycemia, a common side effect of some anti-diabetes drugs, including insulin [9]
lectins and invasins), the surface of the particle can be modified